Tags

Type your tag names separated by a space and hit enter

Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women.
Climacteric. 2013 Oct; 16(5):561-7.C

Abstract

BACKGROUND AND AIMS

The metabolic syndrome (MetS) is a constellation of risk factors increasing the risk of developing cardiovascular disease and diabetes. Little information is available on the association between MetS and menopausal status in Iranian women. Therefore, the purpose of the current study was to examine the prevalence and severity of MetS in pre- and postmenopausal women based on two commonly employed assessment criteria.

METHODS

A total of 490 premenopausal and 434 postmenopausal women from the Shiraz Women's Health Cohort Study were included in the study. MetS was defined according to the criteria of the National Cholesterol Education Program-Adult Panel Treatment III (NCEP-ATPIII) and the International Diabetes Federation (IDF). Clinical, biochemical and anthropometric measures were collected from all study participants for determination of MetS.

RESULTS

The majority of participants had at least two components of MetS. Postmenopausal women, compared to premenopausal women, had a higher prevalence of MetS. The prevalences of MetS were 60.2% and 59.4% based on the NCEP-ATPIII and IDF definitions, respectively. Waist circumference, waist-to-hip ratio, blood pressure, and levels of fasting plasma glucose, total cholesterol, low density lipoprotein cholesterol, and triglycerides were higher in postmenopausal women compared to premenopausal women.

CONCLUSIONS

MetS is a major threat to women's health and an aging population, and longitudinal studies to determine the mechanism of postmenopausal MetS are required.

Authors+Show Affiliations

Health Policy Research Center, Shiraz University of Medical Sciences , Shiraz , Iran.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23157491

Citation

Maharlouei, N, et al. "Prevalence of Metabolic Syndrome in Pre- and Postmenopausal Iranian Women." Climacteric : the Journal of the International Menopause Society, vol. 16, no. 5, 2013, pp. 561-7.
Maharlouei N, Bellissimo N, Ahmadi SM, et al. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric. 2013;16(5):561-7.
Maharlouei, N., Bellissimo, N., Ahmadi, S. M., & Lankarani, K. B. (2013). Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric : the Journal of the International Menopause Society, 16(5), 561-7. https://doi.org/10.3109/13697137.2012.727504
Maharlouei N, et al. Prevalence of Metabolic Syndrome in Pre- and Postmenopausal Iranian Women. Climacteric. 2013;16(5):561-7. PubMed PMID: 23157491.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. AU - Maharlouei,N, AU - Bellissimo,N, AU - Ahmadi,S M, AU - Lankarani,K B, Y1 - 2012/11/16/ PY - 2012/11/20/entrez PY - 2012/11/20/pubmed PY - 2014/4/4/medline SP - 561 EP - 7 JF - Climacteric : the journal of the International Menopause Society JO - Climacteric VL - 16 IS - 5 N2 - BACKGROUND AND AIMS: The metabolic syndrome (MetS) is a constellation of risk factors increasing the risk of developing cardiovascular disease and diabetes. Little information is available on the association between MetS and menopausal status in Iranian women. Therefore, the purpose of the current study was to examine the prevalence and severity of MetS in pre- and postmenopausal women based on two commonly employed assessment criteria. METHODS: A total of 490 premenopausal and 434 postmenopausal women from the Shiraz Women's Health Cohort Study were included in the study. MetS was defined according to the criteria of the National Cholesterol Education Program-Adult Panel Treatment III (NCEP-ATPIII) and the International Diabetes Federation (IDF). Clinical, biochemical and anthropometric measures were collected from all study participants for determination of MetS. RESULTS: The majority of participants had at least two components of MetS. Postmenopausal women, compared to premenopausal women, had a higher prevalence of MetS. The prevalences of MetS were 60.2% and 59.4% based on the NCEP-ATPIII and IDF definitions, respectively. Waist circumference, waist-to-hip ratio, blood pressure, and levels of fasting plasma glucose, total cholesterol, low density lipoprotein cholesterol, and triglycerides were higher in postmenopausal women compared to premenopausal women. CONCLUSIONS: MetS is a major threat to women's health and an aging population, and longitudinal studies to determine the mechanism of postmenopausal MetS are required. SN - 1473-0804 UR - https://www.unboundmedicine.com/medline/citation/23157491/Prevalence_of_metabolic_syndrome_in_pre__and_postmenopausal_Iranian_women_ L2 - https://www.tandfonline.com/doi/full/10.3109/13697137.2012.727504 DB - PRIME DP - Unbound Medicine ER -